Fig. 2From: Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysisDistribution of baseline and follow-up A1C levels. a. All subjects. b. Baseline A1C ≥7.0 %. c. Baseline A1C ≥8.0 %. d. Baseline A1C ≥9.0 %. A1C, glycated hemoglobinBack to article page